Susquehanna Fundamental Investments’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
117,282
-28,192
| -19% | -$321K | 0.04% | 406 |
|
|
2025
Q1 | $1.73M | Buy |
+145,474
| New | +$1.73M | 0.02% | 555 |
|
|
2022
Q1 | $459K | Buy |
32,769
+2,688
| +9% | +$37.7K | 0.01% | 1110 |
|
|
2021
Q4 | $871K | Sell |
30,081
-1,361
| -4% | -$39.4K | 0.02% | 703 |
|
|
2021
Q3 | $942K | Buy |
+31,442
| New | +$942K | 0.02% | 892 |
|
|
2021
Q1 | – | Sell |
-8,300
| Closed | -$273K | – | 1593 |
|
|
2020
Q4 | $273K | Sell |
8,300
-700
| -8% | -$23K | 0.01% | 1281 |
|
|
2020
Q3 | $314K | Buy |
+9,000
| New | +$314K | 0.01% | 1049 |
|